Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2020-09-04 Major Shareholding Noti…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document is a regulatory filing from the Swedish Financial Supervisory Authority (Finansinspektionen) regarding a 'flaggningsmeddelande' (flagging notification). It details a change in shareholding by SEB Investment Management AB in CellaVision AB, specifically noting that the holding crossed the 5% threshold. This is a classic major shareholding notification.
2020-09-04 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for CellaVision for the period of Q2 2020. It contains detailed financial tables (Nettoomsättning, EBITDA, etc.), management commentary on business performance, regional analysis, and specific sections on the impact of COVID-19. It is clearly a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report. H1 2020
2020-07-16 Swedish
Earnings Release 2020
Earnings Release Classification · 1% confidence The document provides detailed financial figures, including Net sales, EBITDA margin, Profit/loss before tax, and cash flow, broken down by period (Apr-Jun 2020 and Jan-Jun 2020). It includes a CEO comment, analysis of market development (Americas, EMEA, APAC), innovation updates, and specific mentions of the Annual General Meeting's decision regarding dividends. The structure, content (quarterly financial performance summary), and inclusion of management commentary strongly indicate this is a comprehensive report covering a period shorter than a full year (Q2 results). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not a brief Earnings Release (ER) as it contains extensive narrative and detailed tables, nor is it the full Annual Report (10-K). Q2 2020
2020-07-16 English
CellaVision AB: Zlatko Rihter lämnar VD-posten i CellaVision AB
Board/Management Information Classification · 1% confidence The document is a formal announcement, dated May 29, 2020, stating that the CEO (VD) of CellaVision AB, Zlatko Rihter, is resigning to take a position at another company. It includes quotes from the departing CEO and the Chairman of the Board, details about the transition timeline, and background information about the company. This content directly relates to changes in senior management personnel. Therefore, it fits the definition of Board/Management Information (MANG). The document length is short (3938 chars), but it is a complete announcement of the event, not just a notice that an announcement/report is forthcoming, thus ruling out RPA/RNS based on the 'Menu vs Meal' rule for this specific content type.
2020-05-29 Swedish
CellaVision AB: Zlatko Rihter leaves his position as CEO at CellaVision AB
Board/Management Information Classification · 1% confidence The document explicitly announces the resignation of the President and CEO, Zlatko Rihter, and details his departure timeline and the initiation of a recruitment process. This content directly relates to changes in senior management personnel. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is a direct announcement of a CEO change, making MANG the most appropriate classification.
2020-05-29 English
Annual Report 2019
Annual Report Classification · 1% confidence The document is the 'CellaVision 2019 Årsredovisning' (Annual Report 2019). It contains comprehensive financial statements, management commentary, board information, and audit references for the full fiscal year 2019. It is clearly the primary annual report document, not an announcement or summary. FY 2019
2020-05-26 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.